These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23929012)

  • 1. The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
    Banerjee R; Roxin G; Eliasziw M; Joseph K; Maclean A; Buie WD; Doll C
    Dis Colon Rectum; 2013 Sep; 56(9):1036-42. PubMed ID: 23929012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.
    Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM
    Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
    Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
    Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
    Grew D; Bitterman D; Leichman CG; Leichman L; Sanfilippo N; Moore HG; Du K
    Dis Colon Rectum; 2015 Dec; 58(12):1130-6. PubMed ID: 26544809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-five-year experience with radical chemoradiation for anal cancer.
    Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of hemoglobin in patients with anal cancer treated with chemoradiotherapy.
    Roldán GB; Chan AK; Buckner M; Magliocco AM; Doll CM
    Dis Colon Rectum; 2010 Aug; 53(8):1127-34. PubMed ID: 20628275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.
    Oehler-Jänne C; Huguet F; Provencher S; Seifert B; Negretti L; Riener MO; Bonet M; Allal AS; Ciernik IF
    J Clin Oncol; 2008 May; 26(15):2550-7. PubMed ID: 18427149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of anal cancer patients at the Ottawa hospital.
    Abunassar M; Reinders J; Jonker DJ; Asmis T
    Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
    Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
    Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
    Chen YW; Yen SH; Chen SY; Huang PI; Shiau CY; Liu YM; Lin JK; Wang LW
    J Surg Oncol; 2007 Oct; 96(5):374-80. PubMed ID: 17492635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
    Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
    Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
    Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C
    Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
    Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
    Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation.
    Schernberg A; Huguet F; Moureau-Zabotto L; Chargari C; Rivin Del Campo E; Schlienger M; Escande A; Touboul E; Deutsch E
    Radiother Oncol; 2017 Jul; 124(1):110-117. PubMed ID: 28662871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
    White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
    Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
    Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.